Want to see HK:0474 full AI Analyst Report?
0474 Stock Chart & Stats
HK$0.12
>-HK$0.01(-2.00%)
At close: 4:00 PM EST
HK$0.12
>-HK$0.01(-2.00%)
Day’s Range― - ―
52-Week RangeHK$0.02 - HK$0.14
Previous CloseN/A
Volume12.00K
Average Volume (3M)71.25M
Market Cap
HK$1.01B
Enterprise ValueHK$1.90B
Total Cash (Recent Filing)HK$330.00M
Total Debt (Recent Filing)HK$1.23B
Price to Earnings (P/E)―
Beta0.19
Next Earnings
Dec 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding8,858,127,000
10 Day Avg. Volume32,027,675
30 Day Avg. Volume71,252,001
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)30.59
Price to Sales (P/S)1.88
P/FCF Ratio24.47
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthAceso's strong revenue growth indicates robust demand for its offerings, enhancing its market position and potential for future expansion.
Business Model DiversificationDiversified revenue streams reduce dependency on a single source, providing stability and resilience against market fluctuations.
Gross Profit MarginA healthy gross profit margin suggests efficient production and pricing strategies, supporting long-term profitability potential.
Bears Say
High LeverageHigh leverage increases financial risk, potentially limiting the company's ability to invest in growth and weather economic downturns.
Negative ProfitabilityOngoing losses indicate challenges in achieving profitability, which could hinder long-term financial sustainability and investor confidence.
Weak Cash FlowDeclining cash flow generation limits the company's ability to fund operations and strategic initiatives, impacting long-term growth potential.
Aceso Life Science Group Limited News
0474 FAQ
What was Aceso Life Science Group Limited’s price range in the past 12 months?
Aceso Life Science Group Limited lowest stock price was HK$0.02 and its highest was HK$0.14 in the past 12 months.
What is Aceso Life Science Group Limited’s market cap?
Aceso Life Science Group Limited’s market cap is HK$1.01B.
When is Aceso Life Science Group Limited’s upcoming earnings report date?
Aceso Life Science Group Limited’s upcoming earnings report date is Dec 01, 2026 which is in 148 days.
How were Aceso Life Science Group Limited’s earnings last quarter?
Currently, no data Available
Is Aceso Life Science Group Limited overvalued?
According to Wall Street analysts Aceso Life Science Group Limited’s price is currently Overvalued.
Does Aceso Life Science Group Limited pay dividends?
Aceso Life Science Group Limited pays a Annually dividend of HK$0.06 which represents an annual dividend yield of N/A. See more information on Aceso Life Science Group Limited dividends here
What is Aceso Life Science Group Limited’s EPS estimate?
Aceso Life Science Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aceso Life Science Group Limited have?
Aceso Life Science Group Limited has 8,858,127,000 shares outstanding.
What happened to Aceso Life Science Group Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Aceso Life Science Group Limited?
Currently, no hedge funds are holding shares in HK:0474
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Aceso Life Science Group Limited Stock Smart Score
Company Description
Aceso Life Science Group Limited
Aceso Life Science Group Limited, an investment holding company, engages in the financial services, property leasing and development, and construction machinery businesses in Hong Kong and the United Kingdom. It operates through rental and sale of construction machinery and spare parts business; provision of repair and maintenance and transportation service business; money lending business; provision of asset management, securities brokerage and other financial service business; property leasing business; and property development business segments. The company leases and sells construction machinery, including crawler cranes, mobile cranes, aerial platforms, and foundation equipment, as well as spare parts; and sells construction materials. It also provides repair and maintenance services for construction machinery; transportation services, such as local container delivery, construction site delivery, and heavy machinery transport; mortgaged and personal loans; and money lending, asset management, commodities, futures, securities brokerage, and other financial services. In addition, the company retails men's and women's apparel; and provides group management, administration, and securities investment services. Further, the company involved in trading of futures and bioscience; and urban development businesses. The company was formerly known as Hao Tian Development Group Limited and changed its name to Aceso Life Science Group Limited in October 2020. Aceso Life Science Group Limited was founded in 1985 and is based in Wan Chai, Hong Kong.
Technical Analysis
Options Prices
Currently, No data available
---